Medtecs International Corporation Ltd
SGX:546
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Medtecs International Corporation Ltd
Cash & Cash Equivalents
Medtecs International Corporation Ltd
Cash & Cash Equivalents Peer Comparison
1786
4155
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
Cash & Cash Equivalents
$15.2m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
27%
|
CAGR 10-Years
22%
|
|
V
|
Visco Vision Inc
TWSE:6782
|
Cash & Cash Equivalents
NT$520.8m
|
CAGR 3-Years
30%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
P
|
Pegavision Corp
TWSE:6491
|
Cash & Cash Equivalents
NT$1.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
SciVision Biotech Inc
TWSE:1786
|
Cash & Cash Equivalents
NT$555m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
OK Biotech Co Ltd
TWSE:4155
|
Cash & Cash Equivalents
NT$323m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
See Also
What is Medtecs International Corporation Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
15.2m
USD
Based on the financial report for Dec 31, 2023, Medtecs International Corporation Ltd's Cash & Cash Equivalents amounts to 15.2m USD.
What is Medtecs International Corporation Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
22%
Over the last year, the Cash & Cash Equivalents growth was -16%. The average annual Cash & Cash Equivalents growth rates for Medtecs International Corporation Ltd have been -43% over the past three years , 27% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
